Cite
MLA Citation
D. S. Alberts et al.. “Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211).” International journal of gynecological cancer, vol. 17, no. 4, 2007, pp. 784–788. http://access.bl.uk/ark:/81055/vdc_100137785740.0x000021